Radiology Doctors in Placerville, CA Accepting Medicare

7 Radiology doctors found. Showing 1 - 7

Alexander Cheng-kang Guo, M.D. Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 1100 Marshall Way, Placerville, CA 95667 Phone: 530-626-1166    Fax: 530-626-3826

Robert L Houts, MD Radiology - Body Imaging Medicare: Not Enrolled in Medicare Practice Location: 1100 Marshall Way, Marshall Medical Center, Placerville, CA 95667 Phone: 530-622-1441

Anietie E Okon, M.D. Radiology - Body Imaging Medicare: Accepting Medicare Assignments Practice Location: 1100 Marshall Way, Marshall Medical Center, Placerville, CA 95667 Phone: 530-626-1166    Fax: 530-626-3826

Jonathan Brett Fugitt, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1100 Marshall Way, Marshall Medical Center, Placerville, CA 95667 Phone: 530-626-2774    Fax: 509-248-0178

Richard Wayne Budenz, PHD MD Radiology - Body Imaging Medicare: Not Enrolled in Medicare Practice Location: 1100 Marshall Way, Marshall Medical Center, Placerville, CA 95667 Phone: 530-622-1441

Jerry P Arnold, M.D. Radiology - Body Imaging Medicare: Not Enrolled in Medicare Practice Location: 1100 Marshall Way, Placerville, CA 95667 Phone: 530-622-1441    Fax: 530-626-3826

Algimantas Balciunas, MD Radiology - Body Imaging Medicare: Not Enrolled in Medicare Practice Location: 1100 Marshall Way, Marshall Medical Center, Placerville, CA 95667 Phone: 530-622-1441

News Archive

IMD seeks FDA regulatory clearance for NADiA ProsVue prostate cancer prognostic test

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Molecular Diagnostics (IMD) subsidiary has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for NADiA®ProsVue™, a prostate cancer prognostic test. The test is designed to help physicians identify patients at low risk of cancer recurrence post radical prostatectomy.

The potential therapeutic value of CDK6 inhibitors in critical COVID-19

While drug repurposing has been explored in the context of the current coronavirus disease 2019 (COVID-19) pandemic, the success of this strategy has been limited so far. A new study, released as a preprint on the medRxiv* server, describes a new method of identifying a promising hit among drugs already in use.

New information on limitations and potential for development of transcranial ultrasound therapy

A recent study completed at the University of Eastern Finland provides new information on the limitations and potential new directions for the future development of transcranial ultrasound therapy.

A glimpse into non-waking consciousness of lucid dreamers

When people dream that they are performing a particular action, a portion of the brain involved in the planning and execution of movement lights up with activity. The finding, made by scanning the brains of lucid dreamers while they slept, offers a glimpse into the non-waking consciousness and is a first step toward true "dream reading,".

Read more Medical News

› Verified 5 days ago